PT3045471T - Resumo - Google Patents

Resumo

Info

Publication number
PT3045471T
PT3045471T PT161581418T PT16158141T PT3045471T PT 3045471 T PT3045471 T PT 3045471T PT 161581418 T PT161581418 T PT 161581418T PT 16158141 T PT16158141 T PT 16158141T PT 3045471 T PT3045471 T PT 3045471T
Authority
PT
Portugal
Application number
PT161581418T
Other languages
English (en)
Portuguese (pt)
Inventor
Cottingham Ian
Plaksin Daniel
Boyd White Richard
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39717519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3045471(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of PT3045471T publication Critical patent/PT3045471T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C12Y204/99006—N-Acetyllactosaminide alpha-2,3-sialyltransferase (2.4.99.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT161581418T 2008-04-16 2009-04-16 Resumo PT3045471T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4542408P 2008-04-16 2008-04-16
EP08251528 2008-04-25

Publications (1)

Publication Number Publication Date
PT3045471T true PT3045471T (pt) 2017-06-14

Family

ID=39717519

Family Applications (6)

Application Number Title Priority Date Filing Date
PT161581418T PT3045471T (pt) 2008-04-16 2009-04-16 Resumo
PT97334973T PT2268666E (pt) 2008-04-16 2009-04-16 Recombinante fsh incluindo sialilação alfa 2,3 e alfa 2,6
PT161949250T PT3144318T (pt) 2008-04-25 2009-04-16 Fsh recombinante incluindo sialilação alfa 2,3 e alfa 2,6
PT141787291T PT2808340T (pt) 2008-04-16 2009-04-16 Resumo
PT212128730T PT4015527T (pt) 2008-04-25 2009-04-16 Fsh recombinante incluindo alfa 2,3- e alfa 2,6- sialilação
PT161791215T PT3098234T (pt) 2008-04-25 2009-04-16 Fsh recombinante incluindo alfa 2,3- e alfa 2,6- sialilação

Family Applications After (5)

Application Number Title Priority Date Filing Date
PT97334973T PT2268666E (pt) 2008-04-16 2009-04-16 Recombinante fsh incluindo sialilação alfa 2,3 e alfa 2,6
PT161949250T PT3144318T (pt) 2008-04-25 2009-04-16 Fsh recombinante incluindo sialilação alfa 2,3 e alfa 2,6
PT141787291T PT2808340T (pt) 2008-04-16 2009-04-16 Resumo
PT212128730T PT4015527T (pt) 2008-04-25 2009-04-16 Fsh recombinante incluindo alfa 2,3- e alfa 2,6- sialilação
PT161791215T PT3098234T (pt) 2008-04-25 2009-04-16 Fsh recombinante incluindo alfa 2,3- e alfa 2,6- sialilação

Country Status (29)

Country Link
US (6) US8951967B2 (https=)
EP (7) EP3045471B1 (https=)
JP (7) JP2011519359A (https=)
KR (5) KR20160056960A (https=)
CN (3) CN105906703A (https=)
AR (1) AR071479A1 (https=)
AU (5) AU2009237479B2 (https=)
BR (1) BRPI0910461B8 (https=)
CA (1) CA2725257A1 (https=)
CY (1) CY1115413T1 (https=)
DK (6) DK2808340T3 (https=)
ES (5) ES2468318T3 (https=)
FI (4) FI3098234T3 (https=)
FR (3) FR17C1020I2 (https=)
HR (5) HRP20140535T1 (https=)
HU (9) HUE068565T2 (https=)
IL (2) IL208538A (https=)
LT (8) LT2808340T (https=)
MX (3) MX355457B (https=)
NO (4) NO2017025I1 (https=)
NZ (1) NZ588381A (https=)
PL (6) PL3144318T3 (https=)
PT (6) PT3045471T (https=)
RU (3) RU2682270C2 (https=)
SA (1) SA109300228B1 (https=)
SI (6) SI2268666T1 (https=)
TW (1) TWI488640B (https=)
WO (1) WO2009127826A1 (https=)
ZA (1) ZA201007373B (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
PT2621517E (pt) 2010-09-29 2015-10-16 Ferring Bv Composição para uso no tratamento da infertilidade
WO2012050175A1 (ja) 2010-10-15 2012-04-19 日本ケミカルリサーチ株式会社 糖鎖の非還元末端がマンノース残基である糖蛋白質の製造方法
PL2691119T3 (pl) 2011-03-31 2019-01-31 Ferring B.V. Preparat farmaceutyczny
EP2717904A1 (en) 2011-06-06 2014-04-16 Ferring BV Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
WO2013093760A2 (en) * 2011-12-19 2013-06-27 Grifols, S.A. Compositions, methods, and kits for preparing sialylated recombinant proteins
US9657310B2 (en) * 2012-04-27 2017-05-23 Jcr Pharmaceuticals Co., Ltd. Expression vector
EP2824176A1 (en) 2013-07-11 2015-01-14 Siamed'xpress Methods for producing sialylated therapeutic proteins
JP6652334B2 (ja) * 2014-05-31 2020-02-19 Ｊｃｒファーマ株式会社 ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
WO2016102436A1 (en) * 2014-12-22 2016-06-30 F. Hoffmann-La Roche Ag Cmp-dependent sialidase activity
EP3283097B1 (en) 2015-04-17 2020-02-12 Ferring B.V. Fsh for treatment of infertility
MY179524A (en) 2015-06-26 2020-11-10 Ferring Bv Methods of purification and/or viral inactivation
EP3205719A1 (en) * 2016-02-15 2017-08-16 CEVEC Pharmaceuticals GmbH Cell lines for producing recombinant glycoproteins with di-antennary n-glycans, methods using the same, and recombinant glycoproteins
GB201603280D0 (en) 2016-02-24 2016-04-13 Ferring Bv Stable liquid gonadotropin formulation
EP3382014A1 (en) * 2017-03-29 2018-10-03 CEVEC Pharmaceuticals GmbH Recombinant glycoproteins with reduced antennary fucosylation
EP3441471A1 (en) 2017-08-08 2019-02-13 CEVEC Pharmaceuticals GmbH Use of constitutively active variants of growth factor receptors as selection makers for the generation of stable producer cell lines
MX2020002235A (es) 2017-09-01 2020-07-20 Ferring Bv Composicion para la estimulacion ovarica controlada.
HUE071268T2 (hu) 2018-04-30 2025-08-28 Ferring Bv Készítmény szabályozott petefészek-stimuláláshoz
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
US20220380785A1 (en) * 2019-11-01 2022-12-01 The University Of British Columbia Compositions and methods for sialylated mucin-type o-glycosylation of therapeutic proteins
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
KR20240167660A (ko) 2022-04-01 2024-11-27 훼링 비.브이. 불임의 치료를 위한 혼합 프로토콜
AU2023275943A1 (en) 2022-05-26 2024-10-17 Ferring B.V. Compositions and methods for treatment of infertility in males
KR20250033230A (ko) 2022-07-08 2025-03-07 훼링 비.브이. 자궁내 인공수정(iui)을 위한 조성물 및 방법
AR133300A1 (es) 2023-07-20 2025-09-17 Ferring Bv Micropartículas cargadas con fármaco de liberación prolongada

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206302B (it) 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US5541083A (en) 1989-10-24 1996-07-30 The Regents Of The University Of California Method for producing secretable glycosyltransferases and other golgi processing enzymes
IL160406A0 (en) 1995-06-15 2004-07-25 Crucell Holland Bv A cell harbouring nucleic acid encoding adenoritus e1a and e1b gene products
JP3559652B2 (ja) * 1996-06-25 2004-09-02 グローリー工業株式会社 売上精算システムの管理装置
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
JP2001507215A (ja) 1997-01-16 2001-06-05 サイテル コーポレイション 組換え糖タンパク質のインビトロでの実用的なシアリル化
JPH1111665A (ja) 1997-06-28 1999-01-19 Shibuya Kogyo Co Ltd 無菌エア搬送コンベヤ装置
TWI235158B (en) * 1997-09-01 2005-07-01 Kirin Brewery Human thrombopoietin produced by human established cell lines, processes foe preparing the same, and pharmaceutical composition comprising the same
PT1176976E (pt) 1999-05-07 2006-11-30 Applied Research Systems Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias.
JP2002011665A (ja) 2000-06-28 2002-01-15 Sintokogio Ltd ショットブラスト装置モニタシステム
IL140110A0 (en) 2000-12-05 2002-02-10 Applied Research Systems Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
MEP38608A (en) * 2001-10-22 2011-02-10 Merck Serono Sa Gonadotrophins for folliculogenesis
ATE542904T1 (de) 2001-10-29 2012-02-15 Crucell Holland Bv Verfahren und mittel zur herstellung von proteinen mit vorbestimmten posttranslationalen modifikationen
PT1465987E (pt) 2001-12-07 2008-04-15 Crucell Holland Bv Produção de vírus, isolados virais e vacinas
US20040248784A1 (en) 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
JP2007515410A (ja) * 2003-12-03 2007-06-14 ネオス テクノロジーズ インコーポレイテッド ＧｌｙｃｏＰＥＧ化卵胞刺激ホルモン
ES2350298T3 (es) 2004-02-04 2011-01-20 Centre National De La Recherche Scientifique Procedimiento para el cribado de anticuerpos específicos de glicoforma.
CN103627670B (zh) * 2004-02-13 2016-12-21 格莱克托普有限公司 高活性糖蛋白加工条件及其有效生产方法
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
US8790322B2 (en) 2010-08-03 2014-07-29 King Saud University Stoma coat
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
PT2621517E (pt) 2010-09-29 2015-10-16 Ferring Bv Composição para uso no tratamento da infertilidade
PL2691119T3 (pl) 2011-03-31 2019-01-31 Ferring B.V. Preparat farmaceutyczny
EP2717904A1 (en) 2011-06-06 2014-04-16 Ferring BV Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
MX2016013449A (es) 2014-04-18 2017-05-04 Glycotope Gmbh Hiperestimulacion ovarica controlada con la hormona estimuladora folicular humana recombinante mejorada.

Also Published As

Publication number Publication date
KR20190092608A (ko) 2019-08-07
EP2268666B1 (en) 2014-03-12
US20240327487A1 (en) 2024-10-03
RU2682270C2 (ru) 2019-03-18
AU2017225020B2 (en) 2019-11-14
HRP20241187T1 (hr) 2024-12-06
AU2014203277C1 (en) 2017-07-27
HUS1700025I1 (hu) 2017-06-28
RU2014141994A3 (https=) 2018-05-28
US11952407B2 (en) 2024-04-09
JP2018021037A (ja) 2018-02-08
DK4015527T3 (da) 2025-04-14
CN105906703A (zh) 2016-08-31
ES2989729T3 (es) 2024-11-27
IL230571A (en) 2015-11-30
US9546204B2 (en) 2017-01-17
JP2020040956A (ja) 2020-03-19
AU2009237479A1 (en) 2009-10-22
HUS1700036I1 (hu) 2017-10-30
RU2014141994A (ru) 2016-05-10
PT3098234T (pt) 2024-10-21
ES2629392T3 (es) 2017-08-09
ES3023526T3 (en) 2025-06-02
RU2537268C2 (ru) 2014-12-27
SI3045471T1 (sl) 2017-07-31
BRPI0910461A2 (pt) 2018-03-27
AU2017225020A1 (en) 2017-09-28
PT2268666E (pt) 2014-06-25
US20150065695A1 (en) 2015-03-05
LT2808340T (lt) 2016-11-10
CY1115413T1 (el) 2017-01-04
IL208538A (en) 2014-03-31
US20110105398A1 (en) 2011-05-05
SI3144318T1 (sl) 2020-12-31
PT2808340T (pt) 2016-11-21
AU2009237479B2 (en) 2014-05-15
CN102066414A (zh) 2011-05-18
DK3045471T3 (en) 2017-06-26
US20180079794A1 (en) 2018-03-22
FR17C1020I2 (fr) 2020-04-10
HRP20250313T1 (hr) 2025-05-09
CA2725257A1 (en) 2009-10-22
US9771407B2 (en) 2017-09-26
EP3144318A1 (en) 2017-03-22
MX2010011343A (es) 2011-01-20
PL4015527T3 (pl) 2025-05-26
MX348622B (es) 2017-06-22
US20160347811A1 (en) 2016-12-01
US8951967B2 (en) 2015-02-10
EP2268666A1 (en) 2011-01-05
RU2745557C1 (ru) 2021-03-29
LT3045471T (lt) 2017-07-10
HUE068565T2 (hu) 2025-01-28
PT4015527T (pt) 2025-04-10
RU2745557C3 (ru) 2021-12-10
JP2017060476A (ja) 2017-03-30
AU2014203277A1 (en) 2014-07-24
SI4015527T1 (sl) 2025-05-30
FIC20250025I1 (fi) 2025-07-11
EP3045471B1 (en) 2017-03-29
DK2808340T3 (en) 2016-12-05
LT4015527T (lt) 2025-04-10
SI2808340T1 (sl) 2016-12-30
KR20170110741A (ko) 2017-10-11
KR102108377B1 (ko) 2020-05-08
HRP20161520T1 (hr) 2016-12-30
AU2017204258A1 (en) 2017-07-20
EP3045471A1 (en) 2016-07-20
EP3098234B1 (en) 2024-07-31
DK2268666T3 (da) 2014-05-12
NO2017050I1 (no) 2017-09-28
LTPA2025525I1 (https=) 2025-07-25
PL3098234T3 (pl) 2025-01-07
KR101622944B1 (ko) 2016-05-23
LTPA2017018I1 (lt) 2017-06-26
KR20180095140A (ko) 2018-08-24
FR25C1003I1 (fr) 2025-02-28
AU2017204259A1 (en) 2017-07-20
AU2014203277B2 (en) 2017-04-06
EP2808340B1 (en) 2016-08-17
CN105906702A (zh) 2016-08-31
JP2015120696A (ja) 2015-07-02
ZA201007373B (en) 2011-06-29
HK1199039A1 (en) 2015-06-19
JP6762916B2 (ja) 2020-09-30
NO2025032I1 (no) 2025-07-14
DK3098234T3 (da) 2024-10-21
PL2268666T3 (pl) 2014-08-29
JP2022031652A (ja) 2022-02-22
HUE030652T4 (en) 2017-09-28
EP3098234A1 (en) 2016-11-30
HUE030652T2 (en) 2017-05-29
US12516094B2 (en) 2026-01-06
SI3098234T1 (sl) 2024-10-30
EP2808340A1 (en) 2014-12-03
TWI488640B (zh) 2015-06-21
RU2010141908A (ru) 2012-05-27
PL2808340T3 (pl) 2017-02-28
NZ588381A (en) 2012-05-25
DK3144318T3 (da) 2020-12-07
EP2722339A1 (en) 2014-04-23
FI3098234T3 (fi) 2024-10-31
BRPI0910461B8 (pt) 2021-05-25
JP7316905B2 (ja) 2023-07-28
ES2610277T3 (es) 2017-04-26
HK1146284A1 (en) 2011-05-20
AU2017204258B2 (en) 2017-08-17
EP4015527A1 (en) 2022-06-22
PL3045471T3 (pl) 2017-10-31
PL3144318T3 (pl) 2021-02-08
JP2024038000A (ja) 2024-03-19
FR17C1020I1 (https=) 2020-04-10
HUE033830T2 (en) 2018-01-29
EP3144318B1 (en) 2020-09-23
LTPA2025505I1 (https=) 2025-02-10
JP2011519359A (ja) 2011-07-07
TW200948378A (en) 2009-12-01
KR20160056960A (ko) 2016-05-20
US10995128B2 (en) 2021-05-04
WO2009127826A1 (en) 2009-10-22
AR071479A1 (es) 2010-06-23
HRP20170958T1 (hr) 2017-09-22
HRP20140535T1 (hr) 2014-07-18
JP6486310B2 (ja) 2019-03-20
KR20110005863A (ko) 2011-01-19
NO2017025I1 (no) 2017-06-06
HUS2500029I1 (hu) 2025-07-28
BRPI0910461A8 (pt) 2018-10-16
FIC20250003I1 (fi) 2025-01-15
FI4015527T3 (fi) 2025-04-29
HUS2500008I1 (hu) 2025-02-28
EP4015527B1 (en) 2025-01-22
MX355457B (es) 2018-04-19
SA109300228B1 (ar) 2014-04-08
NO2025006I1 (no) 2025-01-16
PT3144318T (pt) 2020-11-04
ES2468318T3 (es) 2014-06-16
BRPI0910461B1 (pt) 2021-02-23
FR25C1025I1 (fr) 2025-09-19
HUE071059T2 (hu) 2025-07-28
SI2268666T1 (sl) 2014-07-31
AU2017204259B2 (en) 2017-08-17
IL208538A0 (en) 2010-12-30
HUS1700024I1 (hu) 2017-06-28
LT3098234T (lt) 2024-09-10
US20210332099A1 (en) 2021-10-28
LTPA2017029I1 (lt) 2017-10-10

Similar Documents

Publication Publication Date Title
PT2813570T (pt) Resumo
PT3045471T (pt) Resumo
DK2370462T3 (da) Glucagon-analoger
DK2342317T3 (da) Hængende-dråbe-plade
DE602009000234D1 (de) msignals
BRPI0907376A2 (pt) Fotobiorretador
DK3444343T3 (da) Polypeptider
EP2368526A4 (en) INSERTION TOOL FOR AN INTRAOCULAR LENS
EP2336764A4 (en) LIQUID CHROMATOGRAPH
DE602008003972D1 (de) Sitzrücklehnungsmechanismus
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
DK2342454T3 (da) Vindkraftanlæg
DK2336132T3 (da) Morpholinpurinderivat
EP2368115A4 (en) ANALYTE DETECTION TEST
DK2335031T3 (da) In-line-måler
EP2308156A4 (en) STEP ACTUATOR
DK2379557T3 (da) Aminopyrazol-forbindelse
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
DE602008003970D1 (de) Strahlstromkalibriersystem
EP2257170A4 (en) TETRAHYDROFUROPYRIDONE
EP2248964A4 (en) DRILLING / TERMINAL DEVICE
BRPI0907522A2 (pt) biarlamidas
EP2318641A4 (en) TOOL FOR CENTERING FOR DRILLING ENCLOSURE
EP2360457A4 (en) Gas shutoff device
DE112009000183A5 (de) Sicherheitsvorreiber